Description of a case of severe Q fever


Cite item

Full Text

Abstract

The paper considers a rare clinical case of severe Q fever in a young man with no compromised premorbid background. It describes and analyzes clinical manifestations and laboratory findings with consideration for the current data available in the literature. The issues of the differential diagnosis, laboratory diagnosis, and treatment of Q fever are discussed.

References

  1. Derrick E.H. «Q» fever, a new fever entity: clinical features, diagnosis and laboratory investigation. Med J Australia. 1937;2:281-299.
  2. McDade JE. Historical aspects of Q fever. In: Marrie TJ (ed). Q fever. Volume I. The Disease. Boston: CRC Press; 1990.
  3. Weisburg WG, Dobson ME, Samuel JE, Dasch GA, Mallavia LP, Baca O, Mandelco L, Sechrest JE, Weiss E, Woese CR. Phylogenetic diversity of the Rickettsiae. J Bacteriol. 1989;171(8):4202-4206.
  4. Georgiev M, Afonso A, Neubauer H, Needham H, Thiéry R, Rodolakis A, Roest HJ, Stärk KD, Stegeman JA, Vellema P, van der Hoek W, More SJ. Q fever in humans and farm animals in four european countries, 1982 to 2010. Euro Surveill. 2013;18(8): pii=20407.
  5. Schimmer B, Notermans DW, Harms MG, Reimerink JH, Bakker J, Schneeberger P, Mollema L, Teunis P, van Pelt W, van Duynhoven Y. Low seroprevalence of Q fever in The Netherlands prior to a series of large outbreaks. Epidemiol Infect. 2012;140(1):27-35.
  6. Тарасевич И.В. Современные представления о риккетсиозах. Клиническая микробиология и антимикробная химиотерапия. 2005;2:119-129.
  7. Тарасевич И.В., Демидова Т.Н., Пантюхина А.Н. Вспышка Q лихорадки и болезни кошачьей царапины в Московской области. Журнал микробиологии, эпидемиологии, иммунобиологии. 2012;6:120-121.
  8. McQuiston JH, Childs JE. Q fever in humans and animals in the United States. Vector Borne Zoonotic Dis. 2002;2(3):179-191.
  9. Q fever. OIE Terrestrial Manual, Chapter 2.1.12. World Organisation for Animal Health (2010). Version adopted by the World Assembly of Delegates of the OIE, May 2010. Accessed on April 10, 2012:13.
  10. Касаткина И.Л. Ку-лихорадка. М.: Медгиз; 1963.
  11. Федеральный центр гигиены и эпидемиологии РФ. Инфекционная и паразитарная заболеваемость. Доступно по: http://www.fcgie.ru/
  12. Buhariwalla F, Cann B, Marrie TJ. A dog-related outbreak of Q fever. Clin Infect Dis. 1996;23(4):753-755.
  13. Komiya T, Sadamasu K, Kang MI, Tsuboshima S, Fukushi H, Hirai K. Seroprevalence of Coxiella burnetii infections among cats in different living environments. J Vet Med Sci. 2003;65(9):1047-1048.
  14. Maurin M, Raoult D. Q Fever. Clin Microbiol Rev. 1999;12(4):518-553.
  15. Лобан К.М., Лобзин Ю.В., Лукин Е.П. Ку-лихорадка. В кн.: Риккетсиозы человека. Руководство для врачей. М., СПб.: ЭЛБИ; 2002.
  16. Anderson A, Bijlmer H., Fournier РE, Graves S, Hartzell J, Kersh GJ, Limonard G, Marrie TJ, Massung RF, McQuiston JH., Nicholson WL, Paddock CD, Sexton DJ. Diagnosis and Management of Q Fever- United States, 2013: Recommendations from the CDC and the Q Fever Working Group. MMWR. 2013;62(3):1-23.
  17. Нафеев А.А., Безик В.В. Случай лихорадки Ку на неэндемичной территории. Эпидемиология и инфекционные болезни. 2012;6:38-40.
  18. Schimmer B, Dijkstra F, Vellema P, Schneeberger PM, Hackert V, ter Schegget R, Wijkmans C, van Duynhoven Y, van der Hoek W. Sustained intensive transmission of Q fever in the south of the Netherlands, 2009. EuroSurveill. 2009;14(19):pii=19210.
  19. Anderson AD, Kruszon-Moran D, Loftis AD, McQuillan G, Nicholson WL, Priestley RA. Seroprevalence of Q Fever in the United States, 2003—2004. Am J Trop Med Hyg. 2009;81(4):691-694.
  20. Евстигнеева А.С., Ульянова Т.Ю., Тарасевич И.В. Выживаемость Coxiella burnetii в почве. Почвоведение. 2007;5:622-626.
  21. Jones RM, Nicas M, Hubbard A, Reingold A. The infectious dose of Coxiella burnetii (Q Fever). Applied Biosafety. 2006;11(1):32-41.
  22. Herrin B, Mahapatra S, Blouin EF, Shaw EI. Growth of Coxiella burnetii in the Ixodes scapularis-derived IDE8 tick cell line. Vector Borne ZoonoticDis. 2011;11(7):917-922.
  23. Signs KA, Stobierski MG, Gandhi TN. Q Fever cluster among raw milk drinkers in Michigan, 2011. Clin Infect Dis. 2012;55(10):1387-1389.
  24. Кашуба Э.А., Дроздова Т.Г. Ку-лихорадка. В кн.: Н.Д. Ющук, Ю.Я. Венгеров (ред.). Инфекционные болезни. Национальное руководство. ГЭОТАР-Медиа; 2008.
  25. Angelakis E, Raoult D. Q fever. Vet microbiol. 2010;140(3-4):297-309.
  26. Tissot-Dupont H, Raoult D, Brouqui P, Janbon F, Peyramond D, Weiller PJ, Chicheportiche C, Nezri M, Poirier R. Epidemiologic features and clinical presentation of acute Q fever in hospitalized patients: 323 French cases. Am J Med. 1992;93(4):427-434.
  27. Maltezou HC, Raoult D. Q fever in children. Lancet Infect Dis. 2002;2 (11):686-691.
  28. Tissot-Dupont H, Vaillant V, Rey S, Raoult D. Role of sex, age, previous valve lesion, and pregnancy in the clinical expression and outcome of Q fever after a large outbreak. Clin Infect Dis. 2007;44(2):232-237.
  29. Leone M, Honstettre A, Lepidi H, Capo C, Bayard F, Raoult D, Mege JL. Effect of sex on Coxiella burnetii infection: protective role of 17β-estradiol. J Infect Dis. 2004;189(2):339-345.
  30. Fournier PE, Marrie TJ, Raoult D. Diagnosis of Q fever. J Clin Microbiol. 1998;36(7):1823-1834.
  31. Marrie TJ, Stein A, Janigan D, Raoult D. Route of infection determines the clinical manifestations of acute Q fever. J Infect Dis. 1996;173(2):484-487.
  32. Малеев В.В., Василькова В.В., Галимзянов Х.М., Баклаушева Е.Н., Юсупалиева Л.С. Особенности клинического течения коксиеллеза в Астраханской области. Инфекционные болезни. 2004;1:92-96.
  33. Воробьев А.И., Бриллиант М.Д., Воробьев ПЛ. Лейкемоидные реакции. В кн.: А.И. Воробьев (ред). Руководство по гематологии. М.: Ньюдиамед; 2003.
  34. Малов В.А., Пак С.Г. Медико-биологические аспекты проблемы интоксикации в инфекционной патологии. Терапевтический архив. 1992;11:7-11.
  35. Грачев С.В., Пак С.Г., Малов В.А., Городнова Е.А. Современные аспекты патогенеза сепсиса. Терапевтический архив. 2003;11:84-89.
  36. Городнова Е.А., Пак С.Г., Малов В.А., Грачев С.В., Белобородов В.Б. Клинико-патофизиологическое исследование протеина С у больных генерализованной формой менингококковой инфекции. Вестник РАМН. 2004;6:8-13.
  37. Yaegashi Y, Shirakawa K, Sato N, Suzuki Y, Kojika M, Imai S, Takahashi G, Miyata M, Furusako S, Endo S. Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis. J Infect Chemother. 2005;11(5):234-238.
  38. Bas S, Gauthier BR, Spenato U, Stingelin S, Gabay C. CD14 is an acute phase protein. J Immunol. 2004;172(7):4470-4479.
  39. Amano K, Williams JC, Missler SR, Reinhold VN. Structure and biological relationships of Coxiella burnetii lipopolysaccharides. J Bio Chem. 1987;262(10):4740-4747.
  40. Honstettre A, Ghigo E, Moynault A, Capo C, Toman R, Akira S, Takeuchi O, Lepidi H, Raoult D, Mege JL. Lipopolysaccharide from Coxiella burnetii is involved in bacterial phagocytosis, filamentous actin reorganization, and inflammatory responses through Toll-like receptor 4. J Immunol. 2004;172(6):3695-3703.
  41. Capo C, Moynault A, Collette Y, Olive D, Brown EJ, Raoult D, Mege JL. Coxiella burnetii avoids macrophage phagocytosis by interfering with spatial distribution of complement receptor 3. J Immunol. 2003;170(8):4217-4225.
  42. Hartzell JD, Peng SW, Wood-Morris RN, Sarmiento DM, Collen JF, Robben PM, Moran KA. Atypical Q fever in U.S. soldiers. Emerg Infect Dis. 2007;13(8):1247-1249.
  43. Marrie TJ. Coxiella burnetii (Q fever) pneumonia. Clin Infect Dis. 1995;21(Suppl. 3):S253-S264.
  44. Cunha BA, Nausheen S, Busch L. Severe Q fever community-acquired pneumonia (CAP) mimicking Legionnaires’ disease: Clinical significance of cold agglutinins, anti-smooth muscle antibodies and thrombocytosis. Heart Lung. 2009;38(4):354-362.
  45. Marrie TJ, Durant H, Yates L. Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev Infect Dis. 1989;11(14):586-599.
  46. Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax. 2012;67(1):71-79.
  47. Smith DL, Ayres JG, Blair I, Burge PS, Carpenter MJ, Caul EO, Couplands B, Desselberger U, Evans M, Farrell ID, Hawker JI, Smith EG, Wood MJ. A large Q fever outbreak in the West Midlands: clinical aspects. Respir Med. 1993;87(7):509-516.
  48. Levy P, Raoult D, Razongles JJ. Q fever and autoimmunity. Eur JEpidemiol. 1989;5(4):447-453.
  49. Fournier PE, Etienne J, Harle JR, Habib G, Raoult D. Myocarditis, a rare but severe manifestation of Q fever report of 8 cases and review of the literature. Clin Infect Dis. 2001;32(10):1440-1447.
  50. Raoult D, Tissot-Dupont H, Foucault C, Gouvernet J, Fournier PE, Bernit E, Stein A, Nesri M, Harle JR, Weiller PJ. Q fever 1985 to1998. Clinical and epidemiologic features of 1.383 infections. Medicine (Baltimore). 2000;79(2):109-123.
  51. Kowalczewska M, Sekeyová Z, Raoult D. Proteomics paves the way for Q fever diagnostics. Genome Med. 2011;3:50.
  52. Dijkstra F, Riphagen-Dalhuisen J, Wijers N, Hak E, van der Sande MA, Morroy G, Schneeberger PM, Schimmer B, Notermans DW, van der Hoek W. Antibiotic therapy for acute Q fever in the Netherlands in 2007 and 2008 and its relation to hospitalization. Epidemiol Infect. 2011;139(9):1332-1341.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2015 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies